In our series of posts on the miracle MAB Lecanemab, we showed who was behind the hype -
Pharma are using organisations like the US Alzheimer’s Association to make the case for the use of their products. And its influence is pervasive and ubiquitous:
A strange half-study from the mega journal JAMA recently looked at the content and funding of 107 websites…